Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Beam Therapeutics Inc. is a biotechnology company specializing in precision genetic medicines through proprietary base editing technology, which enables precise, efficient single-base genome modifications without double-stranded DNA breaks. Its platform integrates gene editing, delivery modalities, and manufacturing to develop therapies for genetic and hematological diseases, targeting markets with high unmet medical needs. Beam’s business model combines internal development with strategic collaborations to advance and commercialize innovative gene editing treatments.
This description was generated via AI from an annual report. Updated about 1 year ago.